Pipeline


 

We are dedicated to advancing treatments that improve the care and quality of life of patients suffering from life-threatening cardiovascular diseases. Our development programs currently focus on potential treatments for Autosomal Dominant Polycystic Kidney Disease (ADPKD), and Diabetic Nephropathy (DN).